FilingReader Intelligence
Natco Pharma declares INR 2 interim dividend despite revenue decline
August 12, 2025 at 08:09 AM UTC•By FilingReader AI
Natco Pharma Limited reported consolidated revenue of INR 1,390.6 crore for the quarter ended June 30, 2025, down from INR 1,410.7 crore in the same period last year. Net profit after tax reached INR 480.3 crore.
The board declared an interim dividend of INR 2 per equity share for financial year 2025-26, with record date set for August 19, 2025, and payments beginning August 26.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:NATCOPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Natco Pharma publishes news
Free account required • Unsubscribe anytime